Biote (BTMD) Stock: Buy, Sell, or Hold?
BTMD - Biote Corp. Class A Common Stock
$1.33
0.02 (1.53%)
▲
5d:
-14.19%
30d:
-6.34%
90d:
-45.27%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When BTMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BTMD is down 14.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BTMD is down 14.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.89
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$1.80
25.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BTMD is currently trading at $1.33, which is considered oversold relative to its 30-day fair value range of $1.36 to $1.72. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.0) compared to its historical average (3.3). Remarkably, the market is currently pricing in an annual earnings decline of 3.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BTMD is in a downtrend. The price is currently testing key support at $1.30. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BTMD scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.61 (+96.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BTMD is in a downtrend. The price is currently testing key support at $1.30. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BTMD scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.61 (+96.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.36 -
$1.72
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (29/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 96.4% below Wall St target ($2.61)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.36 -
$1.72
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.30
Resistance Level
$1.80
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.96
Wall Street Target
$2.61
(+96.4%)
Revenue Growth (YoY)
-9.5%
Earnings Growth (YoY)
-83.8%
Profit Margin
3.2%
Valuation Discount vs History
-3.3% cheaper
PE vs Historical
3.0 vs 3.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.3%
(market-implied from PE analysis)
1-Year Target
$1.29
(-3%)
2-Year Target
$1.24
(-7%)
3-Year Target
$1.20
(-10%)
3-Yr Target (if PE normalizes)
(PE: 3→3)
$1.34
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 28.6%)
$19.29
(+1350%)
Base:
(SPY PE: 3.0, Growth: 28.6%)
$2.83
(+113%)
Bear:
(PE: 2.5, Growth: 28.6%)
$2.40
(+81%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (9x PE), but valuation improves significantly next year (3x PE) as earnings recover.
Trailing PE: 9.36 | Current EPS (TTM): $0.14
Bull Case
$2.88
(+117%)
Analyst growth 100.0%, PE expands to 10.3
Base Case
$2.62
(+97%)
Market implied 100.0%, PE stable at 9.4
Bear Case
$0.89
(-33%)
Severe decline -20.0%, PE contracts to 8.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.0 to 3.3
Stabilization Target:
$1.48
(+11.7%)
PE Expansion Potential:
+11.7%
Share & Embed Analysis
Last updated: September 13, 2026 6:31 AM ET
Data refreshes hourly during market hours. Next update: 7:31 AM
Data refreshes hourly during market hours. Next update: 7:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 52 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 56 HOLD |
